Leuprorelin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Leuprorelin and local guidelines before prescribing.
GnRH analogue
Mechanism
GnRH agonist.
Uses
Prostate cancer, premenopausal breast cancer, endometriosis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hot flushes, tumour flare, osteoporosis, injection-site reaction.
Interactions
QT-prolonging drugs.
Contraindications and cautions
Pregnancy
Monitoring
PSA, bone density
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Antiandrogen cover for initial flare.
More from the textbook: uses, cautions and other points
- Continuous GnRH (goserelin, leuprorelin) - paradoxically switches off LH and FSH after an initial surge (used in prostate and breast cancer, endometriosis, precocious puberty).
Endocrine: Anatomy Physiology and Pharmacology - GnRH agonists (e.g. leuprorelin) - shrink fibroids before surgery (menopausal side effects; bone loss - short term only).
Gynaecology: Menstrual Disorders - GnRH agonists (goserelin, leuprorelin, triptorelin) - prostate and breast cancer, endometriosis, fibroids, precocious puberty; initial testosterone flare (cover with an anti-androgen such as bicalutamide in prostate cancer - can cause cord compression or urinary obstruction otherwise); then hot flushes, osteoporosis, loss of libido. …
Endocrine: Anatomy Physiology and Pharmacology - Goserelin / leuprorelin | GnRH agonists; tumour flare - anti-androgen cover in prostate cancer.
Endocrine: Anatomy Physiology and Pharmacology - Goserelin / leuprorelin | Prostate cancer ADT; flare - cover with bicalutamide; hot flushes, bone loss, metabolic effects.
Oncology: Urology and Genital cancers - Treatment - GnRH agonist (e.g. leuprorelin, triptorelin) to pause central puberty; treat the underlying cause.
Paediatrics: Growth, development and nutrition - GnRH agonist (leuprorelin, triptorelin) | Central precocious puberty.
Paediatrics: Growth, development and nutrition - GnRH agonists (leuprorelin, goserelin) | Fibroids before surgery, endometriosis; menopausal symptoms and bone loss - add-back HRT.
Gynaecology: Menstrual Disorders
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Oncology: Urology and Genital cancers (1 mention)
- Paediatrics: Growth, development and nutrition (2 mentions)
- Gynaecology: Menstrual Disorders (2 mentions)
- Integrated paediatrics chapter (2 mentions)